StartUp Health has closed its second fund, raising $31 million, from Novartis, Ping An Group, Chiesi Group, GuideWell, Otsuka, Masimo and a collaboratory of strategic partners, entrepreneurs, industry executives and private investors.

StartUp Health Transformer Fund II will invest in and support companies around the world focused on health moonshots. In fact, it has already made multiple investments including Aver, Biome, CareDox, Cohero Health, Doctor.com, Human Longevity Inc., LifeDojo, Nightingale Health, and Zeel.

“From day one, we’ve had a synced vision with the leadership of Novartis, Ping An Group, Chiesi Group, GuideWell, Otsuka and our community of partners,” Steven Krein, co-founder and CEO of StartUp Health, said in a statement. “We believe unique collaborations are required between entrepreneurs pushing innovation forward and the world’s industry leaders in order to solve today’s most complex healthcare challenges.”

StartUp Health has amassed the world’s largest portfolio of over 250 digital health companies from six continents and 21 countries, and has a global network of over 200,000 investors, customers and partners. StartUp Health is backed by leading health systems, payors and pharmaceutical companies committed to collaborating with entrepreneurs dedicated to transforming health by providing capital, expertise and commercialization opportunities to gain traction and scale.